桿狀病毒已在近年來開始應用於基因治療的載體，因此我們希望在基因治療上發展一套便利的程序純化桿狀病毒。我們選擇最適合病毒存在的緩衝液條件，再利用切向流過濾（tangential flow filtration, TFF）將病毒環境溶液置換為緩衝液，最後結合TFF和Con A（Concanavalin A）親和性層析法來純化出高純度的桿狀病毒。TFF是個很省時的超過濾系統，且可以移除部份雜蛋白，回收率約在75%，系統對病毒活性也不會造成損失；而Con A親和性層析法是利用methyl-alpha-D-mannopyranoside沖提病毒，回收率大約有21%，純度方面達到90%以上，純化後病毒也可以維持完整性。這種新建立的桿狀病毒純化方法除了能有高純度，所得到的回收率也遠比先前所用的超高速離心（<1%）和固定化金屬親和性層析（1~2%）來的高，除此之外，使用Con A親和性層析也是一種迅速方便而且容易大量純化的方法，這是第一個利用結合切向流過濾和Con A親和性層析來純化桿狀病毒的方法。

Baculovirus is capable of transducing mammalian cells with high efficiency and has been proved to be a promising vector for in vivo or ex vivo gene therapy. In the context of vaccine and gene therapy applications, high purity of baculovirus is necessary, thus we aimed at developing a simple and rapid purification process. In this study, we used a recombinant baculovirus with Vesicular Stomatitis Virus Glycoprotein（VSV-G）on the viral surface, which has been shown to enhance viral transduction efficiency. We also demonstrated that the pseudotyped viral vector can improve viral stability. In order to develop a simple and rapid purification process for recombinant baculovirus, we used tangential flow filtration（TFF）and Concanavalin A（Con A）affinity Chromatography in series for high purity purification. The former is a convenient method to remove host cell proteins and concentrate recombinant baculovirus prior to chromatographic step with a higher recovery of 75%, and the latter leads to approximately 21% recovery of recombinant baculovirus by elution with methyl-alpha-D-mannopyranoside. The newly developed method resulted in an overall recovery yield（~15%）that was higher than those resulting from immobilized metal affinity chromatography（1~2%）and gradient ultracentrifugation（<1%）. In addition, rapid and large-scale purification and high recovery yield of baculovirus can be achieved using Con A affinity chromatography. This is the first report describing the method of TFF combined with Con A affinity chromatography for baculovirus purification.

參考文獻

Barsoum J, Brown R, McKee M, Boyce FM. 1997. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 8(17):2011-8.
Boyce FM, Bucher NL. 1996. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci U S A 93(6):2348-52.
Brussaard CP, Marie D, Bratbak G. 2000. Flow cytometric detection of viruses. J Virol Methods 85(1-2):175-82.
Chan ZR, Lai CW, Lee HP, Chen HC, Hu YC. 2006. Determination of the baculovirus transducing titer in mammalian cells. Biotechnol Bioeng 93(3):564-71.
Cheshenko N, Krougliak N, Eisensmith RC, Krougliak VA. 2001. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther 8(11):846-54.
Condreay JP, Witherspoon SM, Clay WC, Kost TA. 1999. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci U S A 96(1):127-32.
Coroadinha AS, Silva AC, Pires E, Coelho A, Alves PM, Carrondo MJ. 2006. Effect of osmotic pressure on the production of retroviral vectors: Enhancement in vector stability. Biotechnol Bioeng 94(2):322-9.
Cruz PE, Goncalves D, Almeida J, Moreira JL, Carrondo MJ. 2000. Modeling retrovirus production for gene therapy. 2. Integrated optimization of bioreaction and downstream processing. Biotechnol Prog 16(3):350-7.
Franco Fraguas L, Batista-Viera F, Carlsson J. 2004. Preparation of high-density Concanavalin A adsorbent and its use for rapid, high-yield purification of peroxidase from horseradish roots. J Chromatogr B Analyt Technol Biomed Life Sci 803(2):237-41.
Geraerts M, Michiels M, Baekelandt V, Debyser Z, Gijsbers R. 2005. Upscaling of lentiviral vector production by tangential flow filtration. J Gene Med 7(10):1299-310.
Ghosh S, Parvez MK, Banerjee K, Sarin SK, Hasnain SE. 2002. Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Mol Ther 6(1):5-11.
Grzenia DL, Carlson JO, Czermak P, Han B, Specht RK, Wickramasinghe SR. 2006. Purification of densonucleosis virus by tangential flow ultrafiltration. Biotechnol Prog 22(5):1346-53.
Ho YC, Chen HC, Wang KC, Hu YC. 2004. Highly efficient baculovirus-mediated gene transfer into rat chondrocytes. Biotechnol Bioeng 88(5):643-51.
Ho YC, Chung YC, Hwang SM, Wang KC, Hu YC. 2005. Transgene expression and differentiation of baculovirus-transduced human mesenchymal stem cells. J Gene Med 7(7):860-8.
Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. 1995. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci U S A 92(22):10099-103.
Hu Y-C, Tsai C-T, Chung Y-C, Lu J-T, Hsu JT-A. 2003a. Generation of chimeric baculovirus with histidine-tags displayed on the envelope and its purification using immobilized metal affinity chromatography. Enzyme Microb. Technol. 33:445-452.
Hu YC, Tsai CT, Chang YJ, Huang JH. 2003b. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol Prog 19(2):373-9.
Jarvis DL, Garcia A, Jr. 1994. Long-term stability of baculoviruses stored under various conditions. Biotechniques 16(3):508-13.
Jiang C, Wechuck JB, Goins WF, Krisky DM, Wolfe D, Ataai MM, Glorioso JC. 2004. Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification. J Virol 78(17):8994-9006.
Jorio H, Tran R, Meghrous J, Bourget L, Kamen A. 2006. Analysis of baculovirus aggregates using flow cytometry. J Virol Methods 134(1-2):8-14.
Kaikkonen MU, Raty JK, Airenne KJ, Wirth T, Heikura T, Yla-Herttuala S. 2006. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther 13(4):304-12.
Kost TA, Condreay JP. 2002. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol 20(4):173-80.
Kuiper M, Sanches RM, Walford JA, Slater NK. 2002. Purification of a functional gene therapy vector derived from Moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography. Biotechnol Bioeng 80(4):445-53.
Laemmli UK, Beguin F, Gujer-Kellenberger G. 1970. A factor preventing the major head protein of bacteriophage T4 from random aggregation. J Mol Biol 47(1):69-85.
Lambotte O, Cacoub P, Costedoat N, Le Moel G, Amoura Z, Piette JC. 2003. High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. J Rheumatol 30(5):1027-8.
Logan AC, Nightingale SJ, Haas DL, Cho GJ, Pepper KA, Kohn DB. 2004. Factors influencing the titer and infectivity of lentiviral vectors. Hum Gene Ther 15(10):976-88.
Luckow VA, Summers MD. 1988. Signals important for high-level expression of foreign genes in Autographa californica nuclear polyhedrosis virus expression vectors. Virology 167(1):56-71.
Lyddiatt A, O'Sullivan DA. 1998. Biochemical recovery and purification of gene therapy vectors. Curr Opin Biotechnol 9(2):177-85.
Ma L, Tamarina N, Wang Y, Kuznetsov A, Patel N, Kending C, Hering BJ, Philipson LH. 2000. Baculovirus-mediated gene transfer into pancreatic islet cells. Diabetes 49(12):1986-91.
Mangor JT, Monsma SA, Johnson MC, Blissard GW. 2001. A GP64-null baculovirus pseudotyped with vesicular stomatitis virus G protein. J Virol 75(6):2544-56.
Marie D, Brussaard CPD, Thyrhaug R, Bratbak G, Vaulot D. 1999. Enumeration of marine viruses in culture and natural samples by flow cytometry. Appl Environ Microbiol 65(1):45-52.
Miller DL, Meikle PJ, Anson DS. 1996. A rapid and efficient method for concentration of small volumes of retroviral supernatant. Nucleic Acids Res 24(8):1576-7.
Nicholson LJ, Philippe M, Paine AJ, Mann DA, Dolphin CT. 2005. RNA interference mediated in human primary cells via recombinant baculoviral vectors. Mol Ther 11(4):638-44.
O'Reilly D, Miller L, Luckow V. 1992. Baculovirus expression vector: a laboratory manual. Baculovirus expression vector. New York: W.H. Freeman and Co.
Ozuer A, Wechuck JB, Russell B, Wolfe D, Goins WF, Glorioso JC, Ataai MM. 2002. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnol Prog 18(3):476-82.
Park SW, Lee HK, Kim TG, Yoon SK, Paik SY. 2001. Hepatocyte-specific gene expression by baculovirus pseudotyped with vesicular stomatitis virus envelope glycoprotein. Biochem Biophys Res Commun 289(2):444-50.
Possee RD. 1997. Baculoviruses as expression vectors. Curr Opin Biotechnol 8(5):569-72.
Ray PK, Raychaudhuri S. 1982. Differential binding affinity of immobilized Concanavalin A-Sepharose 4B for normal and myelomatous immunoglobulins. Biomed Pharmacother 36(4):206-10.
Reiser J. 2000. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther 7(11):910-3.
Sandig V, Hofmann C, Steinert S, Jennings G, Schlag P, Strauss M. 1996. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum Gene Ther 7(16):1937-45.
Sarkis C, Serguera C, Petres S, Buchet D, Ridet JL, Edelman L, Mallet J. 2000. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc Natl Acad Sci U S A 97(26):14638-43.
Schagen FH, Rademaker HJ, Rabelink MJ, van Ormondt H, Fallaux FJ, van der Eb AJ, Hoeben RC. 2000. Ammonium sulphate precipitation of recombinant adenovirus from culture medium: an easy method to increase the total virus yield. Gene Ther 7(18):1570-4.
Segura MM, Kamen A, Trudel P, Garnier A. 2005. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Biotechnol Bioeng 90(4):391-404.
Shen CF, Meghrous J, Kamen A. 2002. Quantitation of baculovirus particles by flow cytometry. J Virol Methods 105(2):321-30.
Shi L, Sanyal G, Ni A, Luo Z, Doshna S, Wang B, Graham TL, Wang N, Volkin DB. 2005. Stabilization of human papillomavirus virus-like particles by non-ionic surfactants. J Pharm Sci 94(7):1538-51.
Shoji I, Aizaki H, Tani H, Ishii K, Chiba T, Saito I, Miyamura T, Matsuura Y. 1997. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol 78 ( Pt 10):2657-64.
Smith GE, Summers MD, Fraser MJ. 1983. Production of human beta interferon in insect cells infected with a baculovirus expression vector. Mol Cell Biol 3(12):2156-65.
Summerford C, Samulski RJ. 1999. Viral receptors and vector purification: new approaches for generating clinical-grade reagents. Nat Med 5(5):587-8.
Tani H, Nishijima M, Ushijima H, Miyamura T, Matsuura Y. 2001. Characterization of cell-surface determinants important for baculovirus infection. Virology 279(1):343-53.
Transfiguracion J, Coelho H, Kamen A. 2004. High-performance liquid chromatographic total particles quantification of retroviral vectors pseudotyped with vesicular stomatitis virus-G glycoprotein. J Chromatogr B Analyt Technol Biomed Life Sci 813(1-2):167-73.
Transfiguracion J, Jaalouk DE, Ghani K, Galipeau J, Kamen A. 2003. Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications. Hum Gene Ther 14(12):1139-53.
Transfiguracion J, Jorio H, Meghrous J, Jacob D, Kamen A. 2007. High yield purification of functional baculovirus vectors by size exclusion chromatography. J Virol Methods 142(1-2):21-8.
Ugai H, Yamasaki T, Hirose M, Inabe K, Kujime Y, Terashima M, Liu B, Tang H, Zhao M, Murata T and others. 2005. Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration. Biochem Biophys Res Commun 331(4):1053-60.
Verhoeyen E, Cosset FL. 2004. Surface-engineering of lentiviral vectors. J Gene Med 6 Suppl 1:S83-94.
Wang KC, Wu JC, Chung YC, Ho YC, Chang MD, Hu YC. 2005. Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells. Biotechnol Bioeng 89(4):464-73.
Wickramasinghe SR, Kalbfuss B, Zimmermann A, Thom V, Reichl U. 2005. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. Biotechnol Bioeng 92(2):199-208.